Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Executive Order Gives HHS Power To Disclose True Device, Procedure Costs To Patients

Executive Summary

Despite industry opposition, President Trump signed a cost transparency executive order giving HHS the regulatory power to reveal to the public, health-care facilities’ costs of devices and procedures.

You may also be interested in...



Device-Related Procedure Costs To Be Revealed Under CMS Proposed Payment Rule

US hospitals would have to reveal on a public website their standard charges and insurer-negotiated prices for a long list of device-related procedures, advanced imaging scans, and lab tests under a proposed Centers for Medicare and Medicaid Services rule released on 29 July.

New US State And Proposed Federal Laws Would Stop Specialists From Balance Billing

A crop of new US consumer protection state laws and proposed federal legislation is aimed at stopping medical specialists from the practice of balance billing.

Pathologists, Radiologists, Labs In Crosshairs As US Senate Panel Clears Lower Health Care Cost Act

The Senate HELP Committee has targeted “ancillary service providers” – radiologists, laboratorians, anesthesiologists and pathologists – who frequently serve health-care facilities on an out-of-network basis by requiring HHS rules to limit their reimbursements to the private payer in-network rate, as part of an effort to end surprise billing.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel